Antimicrobial susceptibility of staphylococci from bovine milk samples in routine microbiological mastitis analysis in Finland

The most frequent reason for antimicrobial use in dairy herds is mastitis and knowledge about mastitis-causing pathogens and their antimicrobial susceptibility should guide treatment decisions. The overall objective of this study was to assess antimicrobial resistance (AMR) of staphylococci in mastitic milk samples in Finland. MALDI-ToF MS identified a total of 504 Staphylococcus isolates (260 S. aureus and 244 non-aureus staphylococci, NAS) originating from bovine mastitic milk samples. Phenotypic susceptibility against cefoxitin, ceftiofur, enrofloxacin, gentamycin, oxacillin, penicillin, and tetracycline was evaluated by disk diffusion method and the presence of blaZ, mecA, and mecC genes investigated by PCR. Nitrocefin test assessed these isolates’ beta-lactamase production. The most common NAS species were S. simulans, S. epidermidis, S. chromogenes, and S. haemolyticus. In total, 26.6% of the isolates (18.5% of S. aureus and 35.2% of all NAS) carried the blaZ gene. Penicillin resistance, based on disk diffusion, was lower: 18.8% of all the isolates (9.3% of S. aureus and 28.9% of all NAS) were resistant. Based on the nitrocefin test, 21.5% of the isolates produced beta-lactamase (11.6% of S. aureus and 32.0% of all NAS). Between the Staphylococcus species, the proportion of penicillin-resistant isolates varied, being lowest in S. simulans and highest in S. epidermidis. Resistance to antimicrobials other than penicillin was rare. Of the eight NAS isolates carrying the mecA gene, six were S. epidermidis. One S. aureus isolate carried the mecC gene. Agreement beyond chance, assessed by kappa coefficient, between phenotypic and genotypic resistance tests, was moderate to substantial. Some phenotypically penicillin-susceptible staphylococci carried the blaZ gene but isolates without blaZ or mec genes rarely exhibited resistance, suggesting that the more reliable treatment choice may depend upon genotypic AMR testing. Our results support earlier findings that penicillin resistance is the only significant form of antimicrobial resistance among mastitis-causing staphylococci in Finland.

Introduction

The most frequent reason for antimicrobial use in dairy herds is mastitis (1). Microbiological diagnosis and knowledge of the antimicrobial susceptibility of pathogens form the basis for effective treatment of intramammary infections. Antimicrobial resistance has been a growing global concern during recent decades (2, 3), with solutions to combat the problem requiring joint efforts within both human and veterinary medicine, in a true One Health spirit (4, 5). Antimicrobial use can lead to resistant strains, and resistance mechanisms may be transmitted from one bacterial species or strain to another through mobile genetic elements (6). Monitoring the antimicrobial resistance of mastitis-causing pathogens is important for ensuring the continued availability of efficacious treatments.

In Finland, prudent antimicrobial use guidelines for mastitis therapy are followed: Bacteriologic analysis of milk samples before initiation of antimicrobial treatment is a common practice and penicillin is the drug of choice in mastitis caused by Gram-positive bacteria (7). Additionally, selective dry cow therapy (SDCT) has always been implemented, with only approximately one-fourth of cows receiving antibiotic dry cow treatment at the end of lactation (8). Since 2010, a mastitis diagnosis in Finland has relied predominantly on PCR methodology after the main dairy co-operative in the country switched to PCR in its mastitis laboratory. Later, also a private veterinary diagnostic laboratory and the clinical laboratory at the Department of Production Animal Medicine at the University of Helsinki adopted this technology. Veterinarians occasionally use bacterial culture and selective agar plates in their clinic laboratories to achieve a quick bacterial diagnosis during weekends and on-call work. The commercial PCR kit (PathoProof™ Complete-16 PCR Assay, Thermo Fisher Scientific, Waltham, MA, United States) used in these diagnostic laboratories targets the 15 main mastitis pathogens plus the staphylococcal blaZ gene which codes for beta-lactamase production. Russi et al. (9) reported a discrepancy between a finding of the blaZ gene and phenotypic penicillin resistance, a phenomenon also observable in the clinical laboratory of Production Animal Hospital, Faculty of Veterinary Medicine, University of Helsinki. After adopting the PCR methodology, the laboratory has used both PCR and phenotypic beta-lactamase production tests for determining the antimicrobial susceptibility of staphylococci. Discrepancies in results make treatment decisions challenging.

Staphylococcus spp. are the most prevalent causal agents of intramammary infections in Finland, constituting approximately 64% of all pathogens isolated from IMIs (10). Resistance of staphylococci against antimicrobials other than beta-lactams is infrequently monitored in Finland, since penicillin is the drug of choice for treatment of infections caused by Gram-positive cocci. In routine diagnostics, staphylococcal species, except for Staphylococcus aureus, are not identified beyond genus level in the PCR-based mastitis diagnostics, although some studies have shown differences between the species in antimicrobial susceptibility (11, 12).

Methicillin resistance coded by the mecA and mecC genes is of great concern in both human and veterinary medicine, due to the zoonotic nature and role of S. aureus in both community-acquired and nosocomial infections (13, 14). Although methicillin resistance is rare in staphylococci isolated from bovine mastitis (12, 15, 16), methicillin-resistant S. aureus (MRSA) have appeared rather commonly in swine production (17, 18), in horses, and in companion animals (19–21).

The main objective of this study was to evaluate the antimicrobial susceptibility of mastitis-causing staphylococci against those antimicrobial agents most frequently used in treatment of bovine mastitis and other infectious diseases of cattle. The other objectives were to estimate the prevalence of methicillin resistance, and to compare the genotypic and phenotypic beta-lactamase resistance in these staphylococci.

Materials and methods

Milk samples

The study material comprised milk samples submitted for bacteriologic analysis to the mastitis laboratory of the main Finnish dairy company Valio Ltd. The company is a farmer-owned cooperative with members across the entire country; it processes approximately 80% of all the milk produced in Finland. Finnish dairy farmers and veterinarians frequently send milk samples from clinical mastitis cases to that laboratory for bacteriologic analysis. They typically receive results electronically the next day by text message, by email, or through a herd-health program of the dairy cooperative. Additionally, milk samples from subclinically infected, high-SCC quarters are often collected before treatment, e.g., at dry-off, to ensure selection of the most appropriate and effective treatment. For its mastitis diagnosis, the Valio laboratory uses PathoProof™ Complete-16 PCR Assay (Thermo Fisher Scientific), which targets 15 mastitis-causing microbial species and the staphylococcal blaZ gene. Each week between August and November 2017, the laboratory personnel saved and froze milk samples which according to the PCR assay contained substantial amounts of the DNA of S. aureus (cycle threshold, Ct-value ≤30.0) or non-aureus staphylococci, NAS (Ct-value ≤31.0) for later culturing and antimicrobial susceptibility testing.

Assuming 20% of S. aureus to be penicillin resistant (17), the Epitools calculator, using 80% power and 5% significance level, provided a sample size of 246 S. aureus isolates to estimate the proportion of penicillin-resistant S. aureus with 5% precision (22). Our goal was to collect the same number of NAS isolates. Only one isolate of any staphylococcal species detected in a herd was included in the data analysis, to ensure the observations’ epidemiologic independence. If the staphylococcal species, however, differed from each other, multiple samples and isolates may have been included from the same cow or the same farm,

Isolate culture and speciation

In the laboratory of the Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, the milk samples were thawed, and 10 μL of milk was streaked on sheep-blood agar plates (Oxoid, Thermo Fisher) and incubated for 24 h at +37°C. Potential staphylococcal colonies were identified based on colony morphology and hemolysis and then MALDI-ToF MS (Bruker Maldi Biotyper, Bruker Daltonics Scandinavia AB, Solna, Sweden) determined the species by the direct transfer method (23). The PCR assay identifies NAS only at group level. If, however, MALDI-ToF MS identified more than one NAS species in a sample, isolates of differing species were considered for the study. Similarly, if a sample contained both S. aureus and NAS, both were considered in the study. However, samples positive for differing species and the blaZ gene were excluded from the study, because it is not possible to know which species carried the blaZ gene. Samples with >2 different colony types were excluded from the study.

Susceptibility testing

The antimicrobial susceptibility to cefoxitin, ceftiofur, enrofloxacin, gentamycin, oxacillin, penicillin, and tetracycline was evaluated using the disk diffusion method. The disks (Oxoid, Thermo Fisher) contained cefoxitin 30 μg, ceftiofur 30 μg, enrofloxacin 5 μg, gentamycin 10 μg, oxacillin 1 μg, penicillin 10 μg, and tetracycline 30 μg. For the cut-off/breakpoint values used and their sources see Table 1. The epidemiologic cut-off (ECOFF) values for susceptibility of staphylococcal species were used when available (24). For ceftiofur, the values were CLSI clinical breakpoints for mastitis in cattle (25). For benzylpenicillin, epidemiologic cut-off values exist only for 1 μg disks, whereas we used 10 μg disks, and thus used a CLSI clinical breakpoint value for human staphylococci. Beta-lactamase production of the isolates was tested by use of liquid nitrocefin prepared from nitrocefin powder as recommended by the manufacturer (Nitrocefin Solution, Oxoid, Thermo Fisher).

TABLE 1

Table 1. Epidemiologic cut-off and clinical breakpoint values (mm) for categorizing bacterial isolates as susceptible or resistant in disk diffusion test.

PCR analyses of mecA and mecC genes

The presence of the mecA or mecC genes was analyzed by PCR in 158 isolates with oxacillin inhibition zone ≤20 mm or cefoxitin inhibition zone ≤28 mm, to ensure detection of all mecA- or mecC-positive isolates. The PCR for detection of mecA or mecC was performed as described in DTU (Technical University of Denmark) Food protocols recommended by the EURL-AR (26). The primers for the analyses were mecA1(P4) 5′-TCC AGA TTA CAA CTT CAC CAG G-3′, mecA2(P7) 5′-CCA CTT CAT ATC TTC TAA CG-3′, mecC1(MultiFP) 5′-GAA AAA AAG GCT TAG AAC GCC TC-3′, and mecC2(MultiRP) 5′-GAA GAT CTT TTC CGT TTT CAG C-3′ (Metabion international AG, Steinkirchen, Germany). The mecA-positive S. aureus ATCC 43300 (162 bp) and the mecC-positive S. aureus CCUG 63582 (138 bp) served as control strains. Distilled water served as the negative control.

Statistical analyses

Descriptive statistics (median, minimum, and maximum inhibitory zone diameters and proportions of isolates resistant for each antimicrobial drug) were calculated separately for S. aureus, for the four most prevalent NAS species, and for the other NAS species together as a group. Proportions of the bacteria carrying blaZ or mec genes were calculated. Agreement beyond chance between phenotypic (based on a disk diffusion method and nitrocefin test) and genotypic (carriage of blaZ gene) resistance to penicillin was assessed by kappa coefficient. Statistical analyses were conducted with the Statistical Analysis System, v. 9.4 (SAS Inst Inc., Cary, NC, United States) and Epitools Calculator (22).

Results

The antimicrobial susceptibility of 504 isolates was evaluated and included in the data analysis. These isolates originated from 497 quarter milk samples from 466 cows in 396 herds. Of these isolates, 260 were S. aureus, and 244 belonged to the NAS group. Altogether, 21 differing NAS species were detectable, including six isolates from three species previously included in the genus Staphylococcus: S. lentus (2), S. sciuri (3), and S. vitulinus (1), which recently have been reassigned to a novel genus, Mammaliicoccus (27). The most common NAS species were S. simulans, S. epidermidis, S. chromogenes, and S. haemolyticus, these accounting for approximately 74% (180/244) of all detectable NAS (Table 2). Isolates identified as S. haemolyticus may have included some isolates of a novel species, S. borealis, because MALDI-ToF MS does not differentiate between them (28). Of 28 samples with more than one staphylococcal species, six each contained S. aureus and a NAS species, and two had three different NAS species; the rest, 20 samples, each had two different NAS species. Of the 28 samples, in 21, the blaZ gene was also detectable, and these samples were excluded, because—based on the commercial PCR assay used—distinguishing which bacterial species carried the blaZ gene was impossible. Five blaZ-negative samples contained two different NAS species, one contained S. aureus and a NAS, and one sample had three different NAS species. All other samples had only one species each.

TABLE 2

Table 2. Percentages of isolates carrying the blaZ gene encoding beta-lactamase production, and zone-inhibition diameters for penicillin in the most common staphylococcal species causing intramammary infections in dairy cows.

Resistance to beta-lactams

Based on the detection of the blaZ gene in the PathoProof™ Complete-16 assay, of all 504 staphylococcal isolates, 134 (26.6%), this constituting 8.5% of S. aureus and 35.2% of all NAS, carried the blaZ gene. These could thus be considered resistant to penicillin. Penicillin resistance was lower based on disk diffusion: Of all the isolates, 18.8% (9.3% of S. aureus and 28.9% of all NAS) were penicillin resistant.

Inhibition-zone diameters (median, min, and max) of penicillin, cefoxitin, ceftiofur, and oxacillin for S. aureus, for the four most prevalent NAS species, and for the rest of the NAS group are in Tables 2, 3. Penicillin resistance based on disk diffusion testing was most common in S. epidermidis, of which 70.2% were resistant. The proportion of blaZ-positive S. epidermidis isolates was even higher, 79.6% (Table 2). Distribution of penicillin-inhibition zones, both for S. aureus and all NAS species, was bimodal, and the distribution of wild-type (isolates without acquired resistance) and resistant isolates was largely in agreement with the blaZ-gene occurrence (Figures 1, 2). In contrast to penicillin-inhibition zones, distribution of cefoxitin- and oxacillin-inhibition zones for all staphylococcal species was unimodal, and the blaZ-gene carriers were largely susceptible, especially to cefoxitin (Figures 3, 4). Based on the nitrocefin test, 21.6% of the isolates produced beta-lactamase (11.6% of S. aureus and 32.0% of all NAS; Table 2).

TABLE 3

Table 3. Zone-inhibition diameters for cefoxitin, ceftiofur, and oxacillin in the most common staphylococcal species¹ in dairy-cow intramammary infections.

FIGURE 1

Figure 1. Frequency distribution of penicillin-inhibition zones for Staphylococcus aureus, occurrence of blaZ gene (no = blue; yes = red) and carriage of mecC gene (indicated with +). The cut-off for penicillin resistance in the disk diffusion test was 29 mm. No S. aureus carried mecA gene.

FIGURE 2

Figure 2. Frequency distribution of penicillin-inhibition zones for non-aureus staphylococci (NAS), occurrence of blaZ gene (no = blue; yes = red) and carriage of mecA gene (indicated with ^*). The cut-off for penicillin resistance in the disk diffusion test was 29 mm. No NAS isolates carried mecC gene.

FIGURE 3

Figure 3. Frequency distribution of cefoxitin-inhibition zones for all staphylococcal isolates, occurrence of blaZ gene (no = blue; yes = red) and carriage of mecA (indicated with *) or mecC gene (indicated with +). The cut-off for cefoxitin resistance in the disk diffusion test was 22 mm for S. aureus and 25 mm for non-aureus staphylococci.

FIGURE 4

Figure 4. Frequency distribution of oxacillin inhibition zones for all staphylococcal isolates, occurrence of blaZ gene (no = blue; yes = red) and carriage of mecA (indicated with *) or mecC gene (indicated with +). The cut-off for oxacillin resistance in the disk diffusion test was 20 mm.

Only three isolates were resistant to ceftiofur (0.6%), one each of S. aureus, S. haemolyticus, and M. lentus. Five isolates (1.0%) were resistant to cefoxitin (two S. epidermidis, one S. aureus, one S. haemolyticus, and one S. pettenkoferi). Based on the threshold value for screening of methicillin resistance in S. pseudintermedius and S. schleiferi (24), 68 isolates (13.9%) were classifiable as resistant to oxacillin.

mecA or mecC genes and agreement between different tests on beta-lactam resistance

In total, 158 staphylococcal isolates (84 S. aureus and 74 NAS) were tested for carriage of mecA and mecC. Eight of the NAS isolates carried mecA, six of these being S. epidermidis, one S. haemolyticus, and one M. lentus (Table 2). No S. aureus isolates carried mecA, but one was mecC positive. The penicillin-inhibition zones of the mecA-positive NAS isolates ranged from 6 to 24 mm, indicating penicillin resistance (Figure 2), but much variability existed in the cefoxitin- and oxacillin-inhibition zones. All mec-positive isolates were classified as resistant to penicillin in the disk diffusion test (Figures 1, 2). Of the eight mecA-positive isolates, four, and also the mecC-positive isolate, were resistant to cefoxitin (Figure 3). The mec carriage of the other four isolates would have remained undetected had the screening been based only on cefoxitin disk diffusion and the recommended cut-off values (24).

Of the nine mec-positive isolates, eight were resistant to oxacillin (Figure 4), and thus only one mecA-positive isolate remained undetected by oxacillin disk diffusion and the recommended cut-off value. On the other hand, of the 68 isolates classified as oxacillin resistant, only nine were mec-gene positive. Thus, 59 isolates were classified as oxacillin resistant based on disk diffusion but were mec-negative. Of the eight mecA-positive NAS isolates, seven also carried the blaZ gene, detectable by the PathoProof™ Complete-16 assay. The mecC-positive S. aureus isolate carried no blaZ, but its inhibition zone for penicillin was 19 mm, for ceftiofur 16 mm, for cefoxitin 18 mm, and for oxacillin 14 mm, all indicating its being resistant to all beta-lactam antimicrobials.

Of all isolates, 12 were blaZ PCR-negative but phenotypically resistant to penicillin (inhibition zones ≤28 mm). Two of these carried either the mecA or the mecC gene, but 10 were mec-gene negative. Conversely, 50 blaZ-positive isolates had penicillin inhibition zones ≥29 mm, ranging from 29 to 51 mm, indicating penicillin susceptibility. Five of these isolates had oxacillin inhibition zone diameters ≤19 mm, ranging from 14 to 18 mm (Figure 4).

Agreement beyond chance between phenotypic penicillin resistance based on the disk diffusion test and occurrence of the blaZ gene was moderate for S. aureus (kappa = 0.56) and was substantial for NAS species (kappa = 0.67), as well as for all staphylococcal species assessed together (kappa = 0.64; Table 4). Proportion of negative agreement (ranging from 0.89 to 0.94) was generally higher than proportion of positive agreement. Agreement beyond chance between blaZ occurrence and the nitrocefin test result was moderate (kappa = 0.62); 35.8% of the blaZ-positive isolates were nitrocefin-test negative, and 6.2% of the blaZ -negative isolates were nitrocefin-test positive. Overall, more commonly genotypically resistant isolates (those carrying blaZ or mec genes) were phenotypically susceptible than genotypically susceptible isolates (those without blaZ- or mec genes) were phenotypically resistant. Genotypic tests may be more reliable than phenotypic tests, especially when one is choosing treatment options.

TABLE 4

Table 4. Agreement beyond chance between phenotypic and genotypic penicillin resistance among mastitis-causing staphylococci.

Resistance to other antimicrobials

Resistance to other than beta-lactam antimicrobials was rare (Table 5). None of the isolates were resistant to gentamycin. Resistance to tetracycline was detectable in only six isolates (1.2%), of which three were mecA-positive S. epidermidis, one was S. kloosii, one S. simulans, and one S. xylosus. Resistance to enrofloxacin was detectable in three isolates (0.6%): S. simulans, a mecA-positive S. haemolyticus, and a mecA-positive M. lentus. Overall, the nine mec-positive isolates were the most resistant. All three ceftiofur-resistant isolates (S. aureus, S. haemolyticus, and M. lentus) were mec-gene carriers. In addition to beta-lactam resistance, three of the mec-positive isolates were resistant to tetracycline (all S. epidermidis) and two to enrofloxacin (S. haemolyticus, M. lentus).

TABLE 5

Table 5. Zone inhibition diameters for enrofloxacin, gentamycin, and tetracycline among the most common staphylococcal species¹ isolated from bovine milk.

Discussion

Our study of the antibiotic resistance of mastitis-causing staphylococci in dairy cows found that the most common form of resistance was resistance to penicillin. This is of practical importance because in Finland, penicillin is the drug of choice in mastitis treatments. When mastitis results from penicillin-resistant staphylococci, cloxacillin intramammary treatment is used (7), but antimicrobial treatment of penicillin-resistant staphylococcal mastitis, especially involving S. aureus, is generally not recommended because of the poor cure rate (30–32). Penicillin resistance of all isolates based on disk diffusion was 18.8%, if based on a nitrocefin test was 21.5%, but when based on blaZ gene carriage was higher, 26.6%. The Finnish Food Authority monitored antimicrobial resistance of staphylococci isolated from mastitic milk samples in 2005 and 2012 (15, 33). In 2005, 25% of S. aureus and in 2012, 23% of S. aureus, and 36% of NAS produced beta-lactamase, so it appears that the antimicrobial resistance of mastitis-causing staphylococci in Finland has been declining slightly.

Lower or similar rates of penicillin resistance as in the current study have been detectable in three other Nordic countries (Norway, Sweden, and Denmark). In Sweden, based on beta-lactamase production, 3% of S. aureus isolates and 30% of NAS isolates from clinical mastitis cases were resistant to penicillin; figures based on MIC values were similar or higher: 3% for S. aureus and 38% for NAS (16). In another Swedish study, 34% of NAS isolates from subclinical mastitis were beta-lactamase positive (34). In Norway, 5% of S. aureus and 23% of NAS isolates were penicillin resistant based on disk diffusion (12). In Denmark, 18% of S. aureus and 22% of NAS isolates were penicillin resistant based on MIC values (35). Penicillin resistance levels for NAS, based on MIC values, were lower in Canada, 10% (36), and in Korea, 14% (37). In some other countries, higher proportions of penicillin-resistant staphylococci isolated from bovine milk have also been detectable. In France, of almost 7,000 coagulase-positive Staphylococcus isolates (mainly S. aureus) collected during 2006–2016, 40% were penicillin resistant based on disk diffusion (38). In Brazil, 36% of Staphylococcus isolates from bovine mastitis, mainly S. aureus, were blaZ positive (39). In South Africa, 63% of 142 NAS isolates from bovine subclinical mastitis were penicillin resistant based on disk diffusion (40).

It is worthwhile to note, however, that a direct comparison of the results between studies is difficult, as study populations, sample collection, and sources of the isolates and methods for antimicrobial susceptibility testing differ. Another explanatory factor for differences in penicillin resistance figures may be related to the distribution of NAS species. In a Swedish study by Nyman et al. (34), S. epidermidis was the most common species, involving 26% of the 783 NAS isolates; similarly, in our study, S. epidermidis comprised about 20% of all NAS species. In contrast, in a Canadian study, where the reported penicillin resistance was lower, only 4% of over 1700 NAS isolates were S. epidermidis, and the three most prevalent species: S. chromogenes, S. simulans, and S. xylosus covered 70% of all isolates (36).

Huge differences in penicillin resistance between the Staphylococcus species were detectable both in ours and other studies. In our study, the lowest proportion of penicillin-resistant isolates was in S. simulans, and the highest in S. epidermidis, based on disk diffusion, nitrocefin production, and blaZ carriage. Many other studies have also shown S. simulans to be mainly susceptible to penicillin and shown S. epidermidis to be the staphylococcal species most resistant to penicillin and to several other antimicrobials (12, 36, 37). Multidrug resistance has also been most common in S. epidermidis (11, 40). In addition, S. epidermidis is the Staphylococcus species that most commonly carries the mecA gene coding for methicillin resistance (11, 36, 37), and consistently, of the eight mecA-positive isolates in the current study, six were S. epidermidis.

The prevalence of mec-positive isolates was low in S. aureus (0.4%), and slightly higher (3.3%) in NAS. In FINRES-Vet antimicrobial resistance monitoring in 2012, no S. aureus but five NAS (5.7%) carried the mecA gene (15). In the study by Gindonis et al. (41) which utilized three different Finnish samplings of staphylococci from bovine mastitis from previous studies, 1.5% of S. aureus and 1.8–5.2% of NAS isolates were mec-gene positive. Although in Finland methicillin resistance in mastitis-causing staphylococci is low, it may, in rare cases, cause problems in clinical work. The occurrence of the mec genes is not routinely tested for in mastitis cases. Some blaZ-negative isolates may be mec positive and thus penicillin resistant. The only mecC-positive S. aureus isolate in our study was blaZ negative and was incorrectly classified as penicillin susceptible. Penicillin treatment of these cases would have led to treatment failure.

Besides resulting in ineffective treatments, methicillin-resistant staphylococci can transfer from cows to humans. In general, although staphylococcal lineages are host-specific, host shifts may occur (42, 43). Currently, methicillin resistance of staphylococci is no problem in Finnish dairy production, but in swine production MRSA has emerged. In a year-long survey in 2016–2017, MRSA emerged in 77% of slaughter batches (17). In the same time period, MRSA infections caused by the livestock-associated CC398 have emerged in Finnish swine farmers (44). Some of the mecA-positive isolates in our study were also resistant to tetracycline or enrofloxacin. Although in Finland tetracycline is not the drug of choice for mastitis therapy, it is commonly used for treating other infectious diseases of cattle, especially respiratory diseases. Enrofloxacin is, among antimicrobials, the drug of choice in Finland for severe coliform mastitis.

The oxacillin disk-diffusion test better indicated mecA carriage than did the cefoxitin disk-diffusion test. However, many of the oxacillin disk-diffusion test results were false positive, i.e., mec-negative isolates showing resistance to oxacillin. Neither of the tests was, however, perfect for detecting mec-gene carriage. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Clinical and the Laboratory Standards Institute (CLSI) recommend cefoxitin disk for screening of mecA-mediated beta-lactam resistance in Staphylococcus aureus and NAS (25, 45), but in our study it did not detect potential mecA-positive isolates very effectively. The cefoxitin disk is reported to perform better for mecC screening than does the oxacillin disk (46, 47). The only mecC-positive S. aureus isolate in our study was detectable by both methods. We did not test for the recently detected mec-gene variant mecB (48), and other resistance mechanisms may also exist, such as mutations in the gdpP gene (49).

In Finland, veterinarians choose an antimicrobial drug for treatment of staphylococcal mastitis largely based on the blaZ result in the PCR test (PathoProof™ Complete-16 PCR Assay). After purchasing the equipment for analyzing milk samples with the q-rt PCR methodology, the clinical laboratory at the Department of Production Animal Medicine, University of Helsinki, analyzed milk samples both with PCR and with conventional culturing and detection of beta-lactamase production in staphylococci (Nitrocefin test, ThermoFisher Scientific). The discrepancy between these results has led to a challenge in decision-making regarding the management of an IMI case: what is the likelihood of cure and which antimicrobial to choose, if the case is treated with antimicrobials? Or is it preferable to dry off the infected quarter or even to cull the cow? The discrepancy between blaZ-gene carriage and the phenotypic penicillin resistance detected in our and other studies in veterinary (9, 50) and human (51, 52) medicine is an interesting phenomenon. BlaZ-negative but phenotypically penicillin-resistant S. aureus isolates are scarce (9), but blaZ-positive isolates that are phenotypically penicillin sensitive commonly exist (9, 50, 51). In our study, the blaZ gene was identified with PathoProof™ Complete-16 PCR Assay (Thermo Fisher Scientific) directly from milk, not from cultivated isolates. Therefore, we excluded from the study the samples positive for more than one staphylococcal species and the blaZ gene, as in samples with more than one species it was not possible to distinguish which bacterial species carried the blaZ gene.

Different tests typically show different sensitivities for detection of beta-lactamase production. Pitkälä et al. (53) compared six tests, using the blaZ PCR as the reference method. At least one method was always positive, supporting the potential for beta-lactamase production of the blaZ-positive isolates. Some authors report that tests based on detection of beta-lactamase production (e.g., nitrocefin test, clover leaf test) correlate better with the occurrence of the blaZ gene than does the agar dilution method (54). Others have reported lower sensitivities for these tests (51, 55). The results of the agar dilution and MIC methods depend on the set cut-off values. In our study, the agreement beyond chance between phenotypic penicillin resistance based on the disk diffusion test and occurrence of the blaZ was moderate to substantial, depending on the Staphylococcus species. One possible reason for phenotypically penicillin susceptible but blaZ-positive isolates is impaired function of the blaZ or its regulators, the blaI and blaR genes, because of sequence mutations (56). Whether all blaZ-positive isolates produce beta-lactamase in vivo remains to be solved. Meanwhile, blaZ-positive results should be interpreted as originating from potentially penicillin-resistant isolates. In practice, the possible discrepancy between occurrence of the blaZ gene and penicillin susceptibility may cause problems in antimicrobial treatment of mastitis.

Resistance to enrofloxacin, gentamycin, and tetracycline was rare for us, similarly to findings in most other studies. None of our isolates was resistant to gentamycin, and most of the few isolates resistant to enrofloxacin or tetracycline carried the mecA gene. Fergestad et al. (12) found, among 100 Staphylococcus isolates from clinical mastitis in Norway, only three isolates resistant to gentamycin, and three isolates resistant to tetracycline. Duse et al. (16) found no gentamycin resistance in Swedish bovine mastitis isolates. All of their NAS isolates were susceptible to enrofloxacin and tetracycline, and tetracycline resistance was also rare for S. aureus (16). Chehabi et al. (35) found no gentamycin resistance among 63 Danish S. aureus isolates, with only one isolate being tetracycline resistant. Of 49 Danish NAS isolates, one was gentamycin resistant, and 5 isolates (10%) were tetracycline resistant. The level of resistance among NAS species varies considerably. Nobrega et al. (36) reported 10% tetracycline resistance for their entire NAS group in Canada, but the percentage of resistant isolates of their most common NAS species ranged from 2% in S. chromogenes to 31% in S. xylosus and 32% in S. epidermidis. Among similar findings in South Korea by Kim et al. (37) were tetracycline resistance in 4% of S. chromogenes and in 26% of S. epidermidis.

Conclusion

Our results support earlier findings that penicillin resistance is the only significant form of antimicrobial resistance among mastitis-causing staphylococci in Finland, and the proportion of resistant isolates has not increased. Based on blaZ-gene carriage, less than one-third of all Staphylococcus isolates were resistant to penicillin, and in phenotypic testing, penicillin resistance was even lower. The difference in proportions of penicillin resistance between Staphylococcus species, however, was considerable, lowest in S. simulans and highest in S. epidermidis. Methicillin resistance was rare, except in S. epidermidis, of which 12% were mecA positive. Some phenotypically penicillin-susceptible staphylococci carried the blaZ gene but isolates without blaZ or mec genes rarely exhibited resistance, suggesting that the more reliable treatment choice may depend upon genotypic AMR testing. The drug of choice for mastitis treatments in Finland is penicillin and resistance to antimicrobials other than penicillin was rare. With targeted treatment decisions, based on the knowledge on infection-causing pathogens, it is possible to keep levels of resistance to antimicrobials low.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Author contributions

PRS planned the study. PRS and ST, and H-TT contributed to data organization and statistical analyses. ST wrote the first draft of the manuscript. All authors contributed to the article and approved the submitted version.

Funding

The work was supported by the Walter Ehrström Foundation.

Acknowledgments

The authors are grateful to Valio Ltd. for providing milk samples for the research. Taina Rahkonen is acknowledged for excellent laboratory work.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Jamali, H , Barkema, HW , Jacques, M , Lavallée-Bourget, E-M , Malouin, F , Saini, V, et al. Invited review: incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows. J Dairy Sci. (2018) 101:4729–46. doi: 10.3168/jds.2017-13730

PubMed Abstract | CrossRef Full Text | Google Scholar

2. OIE World Organisation for Animal Health The OIE strategy on antimicrobial resistance and the prudent use of antimicrobials. (2016). Available at: https://www.woah.org/fileadmin/Home/eng/Media_Center/docs/pdf/PortailAMR/EN_OIE-AMRstrategy.pdf (Accessed January 16, 2023).

Google Scholar

3. WHO World Health Organization Overcoming antimicrobial resistance. WHO report on infectious diseases 2000. WHO/CDS/2000.2. 67 p. (2000) Available at: https://apps.who.int/iris/handle/10665/66672 (Accessed January 16, 2023).

Google Scholar

4. Collignon, PJ , and McEwen, SA . One health—its importance in helping to better control antimicrobial resistance. Trop Med Infect Dis. (2019) 4:22. doi: 10.3390/tropicalmed4010022

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Hu, XY , Logue, M , and Robinson, N . Antimicrobial resistance is a global problem – a UK perspective. Eur J Integr Med. (2020) 36:101136. doi: 10.1016/j.eujim.2020.101136

CrossRef Full Text | Google Scholar

6. Partridge, SA , Kwong, SM , Firth, N , and Jensen, SO . Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. (2018) 31:e00088–97. doi: 10.1128/CMR.00088-17

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Rajala-Schultz, P , Nødtvedt, A , Halasa, T , and Persson, WK . Prudent use of antibiotics in dairy cows: the Nordic approach to udder health. Front Vet Sci. (2021) 8:623998. doi: 10.3389/fvets.2021.623998

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Niemi, R , Hovinen, M , and Rajala-Schultz, P . Selective dry cow therapy effect on milk yield and somatic cell count: a retrospective cohort study. J Dairy Sci. (2002) 105:1387–401. doi: 10.3168/jds.2021-20918

CrossRef Full Text | Google Scholar

9. Russi, N , Maito, J , Dieser, SA , Renna, MS , Signorini, ML , Camussone, C, et al. Comparison of phenotypic tests for detecting penicillin G resistance with presence of blaZ gene in Staphylococcus aureus isolated from bovine intramammary infections. J Dairy Res. (2015) 82:317–21. doi: 10.1017/S0022029915000242

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Vakkamäki, J , Taponen, S , Heikkilä, A-M , and Pyörälä, S . Bacteriological etiology and treatment of mastitis in Finnish dairy herds. Acta Vet Scand. (2017) 59:33. doi: 10.1186/s13028-017-0301-4

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Taponen, S , Nykäsenoja, S , Pohjanvirta, T , Pitkälä, A , and Pyörälä, S . Species distribution and in vitro antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitic milk. Acta Vet Scand. (2016) 58:12. doi: 10.1186/s13028-016-0193-8

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Fergestad, ME , De Visscher, A , L’Abee-Lund, T , Ngassam Tchamba, C , Mainil, JG , Thiry, D, et al. Antimicrobial resistance and virulence characteristics in 3 collections of staphylococci from bovine milk samples. J Dairy Sci. (2021) 104:10250–67. doi: 10.3168/jds.2020-19988

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Graffunder, EM , and Venezia, RA . Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. (2002) 49:999–1005. doi: 10.1093/jac/dkf009

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Springer, B , Orendi, U , Much, P , Hoger, G , Ruppitsch, W , Krziwanek, K, et al. Methicillin-resistant Staphylococcus aureus: a new zoonotic agent? Wien Klin Wochenschr. (2009) 121:86–90. doi: 10.1007/s00508-008-1126-y

CrossRef Full Text | Google Scholar

15. FINRES-Vet (2016–2017). Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents. Evira publications 5/2018. Finnish food safety authority Evira, Helsinki, Finland. Available at: https://www.ruokavirasto.fi/globalassets/viljelijat/elaintenpito/elainten-laakitseminen/evira_publications_5_2018.pdf (Accessed December 16, 2022).

Google Scholar

16. Duse, A , Persson-Waller, K , and Pedersen, K . Microbial aetiology, antibiotic susceptibility and pathogen-specific risk factors for udder pathogens from clinical mastitis in dairy cows. Animals. (2021) 11:2113. doi: 10.3390/ani11072113

PubMed Abstract | CrossRef Full Text | Google Scholar

17. FINRES-Vet (2010–2012). Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents. Evira publications 2/2015. Finnish food safety authority Evira, Helsinki, Finland. Available at: https://www.ruokavirasto.fi/globalassets/viljelijat/elaintenpito/elainten-laakitseminen/antibioottiresistenssin_seuranta/finres_vet_070515.pdf (Accessed December 16, 2022)

Google Scholar

18. Feld, L , Bay, H , Angen, Ø , Larsen, AR , and Madsen, AM . Survival of LA-MRSA in dust from swine farms. Ann Work Expo Health. (2018) 62:147–56. doi: 10.1093/annweh/wxx108

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Maddox, TW , Scantlebury, CE , Clegg, PD , Dawson, S , Pinchbeck, GL , and Williams, NJ . A review of the characteristics and treatment of methicillin-resistant Staphylococcus aureus (MRSA) in the horse and a case series of MRSA infection in four horses. Equine Vet Educ. (2010) 22:91–102. doi: 10.1111/j.0957-7730.2009.00026.x

CrossRef Full Text | Google Scholar

20. Petinaki, E , and Spiliopoulou, I . Methicillin-resistant Staphylococcus aureus colonization and infection risks from companion animals: current perspectives. Vet Med Res Rep. (2015) 6:373–82. doi: 10.2147/VMRR.S91313

PubMed Abstract | CrossRef Full Text | Google Scholar

21. FINRES-Vet (2020). Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents. Finnish food authority publications 6/2021. Finnish food authority, Helsinki, Finland. Available at: https://www.ruokavirasto.fi/globalassets/viljelijat/elaintenpito/elainten-laakitseminen/antibioottiresistenssin_seuranta/finnish_food_authority_publications_6_2021_finres-vet_2020.pdf (Accessed December 16, 2022).

Google Scholar

22. Sergeant ESG Epitools Epidemiological Calculators. Ausvet. (2018) Available at: http://epitools.ausvet.com.au (Accessed December 1, 2021)

Google Scholar

23. Cameron, M , Barkema, HW , De Buck, J , De Vliegher, S , Chaffer, M , Lewis, J, et al. Identification of bovine-associated coagulase-negative staphylococci by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a direct transfer protocol. J Dairy Sci. (2017) 100:2137–47. doi: 10.3168/jds.2016-12020

PubMed Abstract | CrossRef Full Text | Google Scholar

24. EUCAST European committee on antimicrobial susceptibility testing European society of clinical microbiology and infectious diseases (2021). Available at: https://www.eucast.org/ (Accessed March 21, 2022).

Google Scholar

25. CLSI Clinical and Laboratory Standard Institute Performance standards for antimicrobial disc and dilution susceptibility tests for bacteria isolated from animals. VET08, 4th Edn. (2008). Available at: www.clsi.org

Google Scholar

26. DTU Food, National Food Institute, Technical University of Denmark Protocol for PCR amplification of mecA, mecC, spa and pvl. (2012). Recommended by the EURL-AR. 2nd version, September 2012. Available at: https://www.eurl-ar.eu/CustomerData/Files/Folders/21-protocols/279_pcr-spa-pvl-meca-mecc-sept12.pdf (Accessed February 22, 2022).

Google Scholar

27. Madhaiyan, M , Wirth, JS , and Saravanan, VS . Phylogenomic analyses of the Staphylococcaceae family suggest the reclassification of five species within the genus Staphylococcus as heterotypic synonyms, the promotion of five subspecies to novel species, the taxonomic reassignment of five Staphylococcus species to Mammaliicoccus gen. Nov., and the formal assignment of Nosocomiicoccus to the family Staphylococcaceae. Int J Syst Evol Microbiol. (2020) 70:5926–36. doi: 10.1099/ijsem.0.004498

CrossRef Full Text | Google Scholar

28. Pain, M , Wolden, R , Jaén-Luchoro, D , Salvà-Serra, F , Piñeiro Iglesias, B , Karlsson, R, et al. Staphylococcus borealis sp. nov., isolated from human skin and blood. Int J Syst Evol Microbiol. (2020) 70:6067–78. doi: 10.1099/ijsem.0.004499

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Dohoo, IR , Martin, W , and Stryhn, H . Veterinary Epidemiologic Research. 2nd ed. Charlottetown: University of Prince Edward Island (2014).

Google Scholar

30. Sol, J , Sampimon, OC , Barkema, HW , and Schukken, YH . Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J Dairy Sci. (2000) 83:278–84. doi: 10.3168/jds.S0022-0302(00)74875-2

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Taponen, S , Jantunen, A , Pyörälä, E , and Pyörälä, S . Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus. Acta Vet Scand. (2003) 44:53–62. doi: 10.1186/1751-0147-44-53

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Barkema, HW , Schukken, YH , and Zadoks, RN . Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci. (2006) 89:1877–95. doi: 10.3168/jds.S0022-0302(06)72256-1

PubMed Abstract | CrossRef Full Text | Google Scholar

33. FINRES-Vet 2005-2006 (2022). Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents. Evira publications 22/2007. Finnish food safety authority Evira, Helsinki, Finland. Available at: https://www.ruokavirasto.fi/globalassets/viljelijat/elaintenpito/elainten-laakitseminen/antibioottiresistenssin_seuranta/finres_vet_22_2007.pdf (Accessed December 16, 2022).

Google Scholar

34. Nyman, A-K , Fasth, C , and Persson, WK . Intramammary infections with different non-aureus staphylococci in dairy cows. J Dairy Sci. (2018) 101:1403–18. doi: 10.3168/jds.2017-13467

CrossRef Full Text | Google Scholar

35. Chehabi, CN , Nonnemann, B , Astrup, LB , Farre, M , and Pedersen, K . In vitro antimicrobial resistance of causative agents to clinical mastitis in Danish dairy cows. Foodborne Pathog Dis. (2019) 16:562–72. doi: 10.1089/fpd.2018.2560

CrossRef Full Text | Google Scholar

36. Nobrega, DB , Naushad, S , Naqvi, SA , Condas, LAZ , Saini, V , Kastelic, JP, et al. Prevalence and genetic basis of antimicrobial resistance in non-aureus staphylococci isolated from Canadian dairy herds. Front Microbiol. (2018) 9:256. doi: 10.3389/fmicb.2018.00256

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Kim, S-J , Moon, DC , Park, S-C , Kang, HY , Na, SY , and Lim, S-K . Antimicrobial resistance and genetic characterization of coagulase-negative staphylococci from bovine mastitis milk samples in Korea. J Dairy Sci. (2019) 102:11439–48. doi: 10.3168/jds.2019-17028

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Boireau, C , Cazeau, G , Jarrige, N , Calavas, D , Madec, J-Y , Leblond, A, et al. Antimicrobial resistance in bacteria isolated from mastitis in dairy cattle in France, 2006–2016. J Dairy Sci. (2018) 101:9451–62. doi: 10.3168/jds.2018-14835

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Lúcio, ÉC , Gouveia, GV , da Costa, MM , de Oliveira, JMB , Mota, RA , and Pinheiro, JWJ . Phenotypic and genotypic characteristics and resistance profile of Staphylococcus spp. from bovine mastitis. Acta Sci Vet. (2020) 48:1759. doi: 10.22456/1679-9216.103434

CrossRef Full Text | Google Scholar

40. Phophi, L , Petzer, IM , and Qekwana, DN . Antimicrobial resistance patterns and biofilm formation of coagulase-negative Staphylococcus species isolated from subclinical mastitis cow Milk samples submitted to the Onderstepoort Milk laboratory. BMC Vet Res. (2019) 15:420. doi: 10.1186/s12917-019-2175-3

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Gindonis, V , Taponen, S , Myllyniemi, A-M , Pyörälä, S , Nykäsenoja, S , Salmenlinna, S, et al. Occurrence and characterization of methicillinresistant staphylococci from bovine mastitis milk samples in Finland. Acta Vet Scand. (2013) 55:61. doi: 10.1186/1751-0147-55-61

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Jaglic, Z , Michu, E , Holasova, M , Vlkova, H , Babak, V , Kolar, M, et al. Epidemiology and characterization of Staphylococcus epidermidis isolates from humans, raw bovine milk and a dairy plant. Epidemiol Infect. (2010) 138:772–82. doi: 10.1017/S0950268809991002

CrossRef Full Text | Google Scholar

43. Sakwinska, O , Giddey, M , Moreillon, M , Morisset, D , Waldvogel, A , and Moreillon, P . Staphylococcus aureus host range and human-bovine host shift. Appl Environ Microbiol. (2011) 77:5908–15. doi: 10.1128/AEM.00238-11

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Salmenlinna, S , Raulo, S , Lindholm, L , Marttila, H , Myllyniemi, A-L , Nykäsenoja, S, et al. MRSA CC398 in people: should the spread of zoonotic antimicrobial resistance be prevented? (in Finnish, MRSA CC398 ihmisillä: Tulisiko zoonottisen mikrobilääkeresistenssin leviäminen estää?). Lääkärilehti. (2021) 76:1813–8.

Google Scholar

45. EUCAST European Committee on Antimicrobial Susceptibility Testing (2017). Detection of resistance mechanisms. European committee on antimicrobial susceptibility testing. Available at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mechanisms_170711.pdf (Accessed February 22, 2022)

Google Scholar

46. Skov, R , Varga, A , Matuschek, E , Åhman, J , Bemis, D , Bengtsson, B, et al. EUCAST disc diffusion criteria for the detection of mecA-mediated b-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin. Clin Microbiol Infect. (2020) 26:122.e1–6. doi: 10.1016/j.cmi.2019.05.002

CrossRef Full Text | Google Scholar

47. Kriegeskorte, A , Idelevich, EA , Schlattman, A , Layer, F , Strommenger, B , Denis, O, et al. Comparison of different phenotypic approaches to screen and detect mecC-harboring methicillin-resistant Staphylococcus aureus. J Clin Microbiol. (2018) 56:e00826–917. doi: 10.1128/JCM.00826-17

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Becker, K , van Alen, S , Idelevich, EA , Schleimer, N , Seggewiß, J , Mellmann, A, et al. Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus. Emerg Infect Dis. (2018) 24:242–8. doi: 10.3201/eid2402.171074

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Sommer, A , Fuchs, S , Layer, F , Schaudinn, C , Weber, RE , Richard, H, et al. Mutations in the gdpP gene are a clinically relevant mechanism for β-lactam resistance in meticillin-resistant Staphylococcus aureus lacking mec determinants. Microb Genom. (2021) 7:623. doi: 10.1099/mgen.0.000623

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Ruegg, PL , Oliveira, L , Jin, W , and Okwumabua, O . Phenotypic antimicrobial susceptibility and occurrence of selected resistance genes in gram-positive mastitis pathogens isolated from Wisconsin dairy cows. J Dairy Sci. (2015) 98:4521–34. doi: 10.3168/jds.2014-9137

PubMed Abstract | CrossRef Full Text | Google Scholar

51. El Feghaly, RE , Stamm, JE , Fritz, SA , and Burnham, C-AD . Presence of the blaZ beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods. Diagn Microbiol Infect Dis. (2012) 74:388–93. doi: 10.1016/j.diagmicrobio.2012.07.013

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Ferreira, AM , Martins, KB , da Silva, VR , Mondelli, AL , and Cunha, (2017). Correlation of phenotypic tests with the presence of the blaZ gene for detection of beta-lactamase. Braz J Microbiol 48:159–166. doi: 10.1016/j.bjm.2016.10.011

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Pitkälä, A , Salmikivi, L , Bredbacka, P , Myllyniemi, A-L , and Koskinen, MT . Comparison of tests for detection of β-lactamase-producing staphylococci. J Clin Microbiol. (2007) 45:2031–3. doi: 10.1128/JCM.00621-07

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Haveri, M , Suominen, S , Rantala, L , Honkanen-Buzalski, T , and Pyörälä, S . Comparison of phenotypic and genotypic detection of penicillin G resistance of Staphylococcus aureus isolated from bovine intramammary infection. Vet Microbiol. (2005) 106:97–102. doi: 10.1016/j.vetmic.2004.12.015

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Kaase, M , Lenga, S , Friedrich, S , Szabados, F , Sakinc, T , Kleine, B, et al. Comparison of phenotypic methods for penicillinase detection in Staphylococcus aureus. Clin Microbiol Infect. (2008) 14:614–6. doi: 10.1111/j.1469-0691.2008.01997.x

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Tasara, T , Cernela, N , and Stephan, R . Function impairing mutations in blaZ and blaR genes of penicillin susceptible Staphylococcus aureus strains isolated from bovine mastitis. Schweiz Arch Tierheilkd. (2013) 155:359–63. doi: 10.1024/0036-7281/a000471

PubMed Abstract | CrossRef Full Text | Google Scholar